❤️TOP 20 REASONS TO LOVE BIEL❤️ 1. It's
Post# of 8529
(Total Views: 267)
Posted On: 04/12/2025 4:50:19 PM
❤️TOP 20 REASONS TO LOVE BIEL❤️
1. It's a real company with real products.
2. The company is not burning $$$ millions every quarter trying to get a product through the FDA wringer. They've accomplished FDA clearance already.
3. The company is very close to profitability every quarter. BIEL will likely be profitable soon, it not already (a $400K quarter should do it).
4. There is no toxic debt. The company is not sinking under death spiral financing.
5. Actipatch has thousands of excellent, mostly 5-star customer reviews.
6. $40 million tax-loss carry forward will make the first $40 million in profits tax free.
7. if $800k revenue is reported for 2024, it will likely gets the pps out of the trips.
8. Technical indicators (Golden Cross, Blue Sky Breakout, etc.) turning positive. Every bull run starts with this.
9. Bare bones expenses: about $750k/year for GENERAL AND ADMIN EXPENSES (salaries, utilities, R&D, Advertising, etc) with a burn rate of about $220k/year for Other Gen and Admin Expenses.
10. New utility patent (pending) for chronic pain inflammation (vagus nerve) is HUGE.
11. Actipatch is a Standard of Care product.
12. They have 5 FDA clearances with more pending.
13. Insurance coverage is expanding - currently covered by the UK National Health Service (and Taiwan?).
14. Been in business for over 20 years.
15. Accepted for use by the Veterans Administration.
16. Rapidly expanding in the veterinary/pet market.
17. New contract/partner rumors swirling.
18. Amazon/Apple type of return on investment (ROI) very possible.
19. Fed forecast to cut interest rates five times this year, which benefits OTC stocks like BIEL greatly. The last time this happened (2021) BIEL surged 1,600%.
20. See 1 - 19!
1. It's a real company with real products.
2. The company is not burning $$$ millions every quarter trying to get a product through the FDA wringer. They've accomplished FDA clearance already.
3. The company is very close to profitability every quarter. BIEL will likely be profitable soon, it not already (a $400K quarter should do it).
4. There is no toxic debt. The company is not sinking under death spiral financing.
5. Actipatch has thousands of excellent, mostly 5-star customer reviews.
6. $40 million tax-loss carry forward will make the first $40 million in profits tax free.
7. if $800k revenue is reported for 2024, it will likely gets the pps out of the trips.
8. Technical indicators (Golden Cross, Blue Sky Breakout, etc.) turning positive. Every bull run starts with this.
9. Bare bones expenses: about $750k/year for GENERAL AND ADMIN EXPENSES (salaries, utilities, R&D, Advertising, etc) with a burn rate of about $220k/year for Other Gen and Admin Expenses.
10. New utility patent (pending) for chronic pain inflammation (vagus nerve) is HUGE.
11. Actipatch is a Standard of Care product.
12. They have 5 FDA clearances with more pending.
13. Insurance coverage is expanding - currently covered by the UK National Health Service (and Taiwan?).
14. Been in business for over 20 years.
15. Accepted for use by the Veterans Administration.
16. Rapidly expanding in the veterinary/pet market.
17. New contract/partner rumors swirling.
18. Amazon/Apple type of return on investment (ROI) very possible.
19. Fed forecast to cut interest rates five times this year, which benefits OTC stocks like BIEL greatly. The last time this happened (2021) BIEL surged 1,600%.
20. See 1 - 19!
(2)
(0)